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Abstract
Amyloid β peptide (Aβ) is the major pathogenic molecule in Alzheimer's disease 
(AD). BACE1 enzyme is essential for the generation of Aβ. Deficiency of p38α- 
MAPK in neurons increases lysosomal degradation of BACE1 and decreases Aβ 
deposition in the brain of APP- transgenic mice. However, the mechanisms mediating 
effects of p38α- MAPK are largely unknown. In this study, we used APP- transgenic 
mice and cultured neurons and observed that deletion of p38α- MAPK specifically 
in neurons decreased phosphorylation of Snapin at serine, increased retrograde 
transportation of BACE1 in axons and reduced BACE1 at synaptic terminals, which 
suggests that p38α- MAPK deficiency promotes axonal transportation of BACE1 
from its predominant locations, axonal terminals, to lysosomes in the cell body. In 
vitro kinase assay revealed that p38α- MAPK directly phosphorylates Snapin. By 
further performing mass spectrometry analysis and site- directed mutagenic experi-
ments in SH- SY5Y cell lines, we identified serine residue 112 as a p38α- MAPK- 
phosphorylating site on Snapin. Replacement of serine 112 with alanine did abolish 
p38α- MAPK knockdown- induced reduction of BACE1 activity and protein level, 
and transportation to lysosomes in SH- SY5Y cells. Taken together, our study sug-
gests that activation of p38α- MAPK phosphorylates Snapin and inhibits the retro-
grade transportation of BACE1 in axons, which might exaggerate amyloid pathology 
in AD brain.
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1 |  INTRODUCTION
Alzheimer's disease (AD) is the main cause of dementia with 
very limited therapeutic options. The amyloid β peptide (Aβ) 
is a key pathogenic molecule in AD, which accumulates in 
the brain and injures neurons directly1,2 and indirectly by trig-
gering neurotoxic inflammation.3 Aβ is produced after serial 
cleavage of Alzheimer's amyloid precursor protein (APP) by 
β- and γ- secretases. The β- site of APP cleaving enzyme 1 
(BACE1) is the rate limiting secretase for Aβ generation.4- 6 
Inhibition of BACE1 might serve as a therapeutic strategy for 
AD patients. p38α- mitogen activated protein kinase (MAPK), 
sensitive to stress stimuli, is activated in neurons and microglia 
in association with Aβ plaques and neurofibrillary tangles.7- 9 
Recently, we observed that deletion of p38α- MAPK in neu-
rons facilitates BACE1 degradation in lysosomes thereby at-
tenuating cerebral Aβ load in APP- transgenic AD mice.10
However, the detailed mechanism through which p38α- 
MAPK deficiency promotes the lysosomal degeneration of 
BACE1 remains unclear. BACE1 is predominantly located at 
axonal terminals, while lysosomes are enriched in the soma. 
Does p38α- MAPK deficiency drive the transportation of 
BACE1 to lysosomes? Previous studies have shown that the 
transport of BACE1- laden endosomes from axons to the soma 
is impaired, which might lead to an accumulation of BACE1. 
The impaired transportation perhaps also stacks APP in late 
endosomes at synaptic terminals. As a result, Aβ production 
and deposition in the brain is enhanced.11,12 Interestingly, 
over- expression of Snapin, a synaptosome- associated protein 
25 (SNAP- 25) binding protein, restores the defective axonal 
transport of BACE1 to lysosomes.13 As a dynein motor adap-
tor, Snapin also regulates trafficking of BACE114,15 and other 
proteins, eg, the tyrosine kinase,16 from the late endosomes 
to lysosomes in neurons. Thus, we hypothesized that p38α- 
MAPK might phosphorylate Snapin and regulate the retro-
grade transport of BACE1 in axons and further into lysosomes.
In our study, we deleted p38α- MAPK specifically in neurons 
of APP- transgenic mice. p38α- MAPK deficiency did decrease 
phosphorylation of Snapin, and reduce BACE1 proteins at axo-
nal terminals in the brain. With mass spectrometry and in vitro 
kinase assay, we identified serine 112 as a potential p38α- MAPK- 
phosphorylating site on Snapin. Replacing serine 112 with ala-
nine abolished p38α- MAPK deficiency- enhanced BACE1 
degradation. Thus, our study suggested that p38α- MAPK activa-
tion contributes to AD pathogenesis by phosphorylating Snapin.
2 |  METHODS
2.1 | Animals
APP- transgenic mice with deletion of p38α- MAPK were es-
tablished in our previous study by cross- breeding between 
APP/PS1- transgenic, mapk14- floxed mice (p38fl/fl), and nex 
gene promoter- driven Cre knock- in mice (Nex- Cre).10,17 All 
mice were analyzed at nine months of age using our estab-
lished protocols.10,17 Animal experiments followed relevant 
national rules and permissions issued by the local research eth-
ical committee (registration numbers: 40/2014 and 43/2017).
2.2 | Snapin phosphorylation assay and 
BACE1 quantification in the brain
Phosphorylation sites on Snapin were predicted by the on-
line software “NetPhos 3.1 Server” (http://www.cbs.dtu.dk/
servi ces/NetPh os- 3.1) and “Group- based prediction system” 
(http://gps.biocu ckoo.org/online.php) using the query se-
quence with UniProt accession number of O95295.
Right brain hemispheres from APPtgp38fl/flNexcre/wt and 
APPtgp38fl/flNexwt/wt littermate mice were homogenized in 
buffer A (50  mM Tris/HCl [pH 7.5], 150  mM NaCl, 1% 
Triton- X100, 2 mM EDTA, 2 mM EGTA, 50 nM ocadaic 
acid, 5 mM sodiumpyrophosphate, 2 mM sodium vanadate, 
50 mM NaF and 150 mM NaCl) supplemented with prote-
ase inhibitor cocktail (Merck KGaA, Darmstadt, Germany) 
and phosphatase inhibitors (500  mM EGTA, 50  nM oca-
daic acid, 5  mM sodiumpyrophosphate, 2  mM sodium 
vanadate, 50 mM NaF; all from Merck KGaA). The post- 
nuclear lysate at 2 mg/mL was pre- cleared with Dynabeads 
M- 280 sheep anti- rabbit IgG (cat. 11203D; Thermo Fisher 
Scientific, Darmstadt, Germany) for 1  hour, and then in-
cubated overnight at 4°C with rabbit polyclonal antibody 
against Snapin (cat. 148002; Synaptic Systems, Göttingen, 
Germany; 1:30 dilution). The antibody- bound Snapin 
was pulled down by magnetic beads- conjugated second 
antibody for another 2  hours at 4°C. After thoroughly 
washing, the immunoprecipitated Snapin was detected 
with Western blotting using rabbit polyclonal antibodies 
against phospho- serine (cat. SAB5200086; Merck KGaA) 
and phosphorylated- threonine (cat. 9381; Cell Signaling 
Technology, Danvers, MA, USA). Total Snapin was de-
tected with Snapin antibody (Synaptic Systems).
The brain homogenate was also detected with Western 
blot for BACE1 and β- actin using rabbit monoclonal anti-
bodies (clone D10E5 and 13E5, respectively; Cell Signaling 
Technology).
2.3 | Immunohistological analysis of Snapin 
in the brain
Serial 50- μm- thick sagittal sections were cut from the paraffin- 
embedded left hemisphere and stained with Snapin antibody 
(Synaptic Systems). Z- stack images with a distance of 0.5 µm 
were taken from hippocampus under Zeiss AxioImager.Z2 
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microscope with 40× objective. The length of linear Snapin 
staining was measured with ImageJ plugin “Skeletonized 3D” 
as we previously did for a measurement of blood vessels.18 
The length of Snapin staining along axons and in the neuropil 
was normalized by the area of region of interest.
2.4 | Synaptosomal isolation from 
mouse brains
Synaptosomes were isolated from right hemispheres of 
APPtgp38fl/flNexcre/wt and APPtgp38fl/flNexwt/wt littermate mice 
according to published methods19,20 with minor modifications. 
Briefly, brain tissues were homogenized in 10× volumes of 
sucrose buffer (2  mM HEPES, pH 7.4, 320  mM sucrose, 
50  mM EDTA, 20  mM DTT) supplemented with protease 
inhibitor cocktail (Merck KGaA) and phosphatase inhibitors, 
and then centrifuged at 3000 g for 2 minutes. The superna-
tant was collected and again centrifuged at 9200 g for 20 min-
utes. After the supernatant containing cytosolic proteins was 
removed, the pellet was resuspended in 1 mL sucrose buffer 
and loaded on a gradient buffer constructed with 23% (4 mL), 
10% (4  mL), and 3% (3  mL) of Percoll (cat. 17- 0891- 02; 
Merck KGaA). The gradient was centrifuged for 17 minutes 
at 10 500 rpm in SW41 rotor (Beckman Coulter, Sinsheim, 
Germany). The band between the 10% and 23% Percoll layers 
containing synaptosomes was collected and washed in PBS.
In the end, synaptosomes were resuspended in 50 µL of 
buffer A. To examine the quality of isolation experiment, the 
lysate of synaptosomes was detected for synaptic proteins with 
rabbit polyclonal antibodies against Grin2a and PSD- 95 (cat. 
4205, and 9212, respectively; Cell Signaling Technology), 
and cytosolic protein, HDAC3, with rabbit monoclonal anti-
body (clone Y415; Novus biologicals, Wiesbaden, Germany). 
Thereafter, synaptosomal lysate was detected with rabbit 
polyclonal antibodies against p38- MAPK (cat. 9212; Cell 
Signaling Technology) and Snapin (Synaptic Systems), and 
with rabbit monoclonal antibody against BACE1 (clone 
D10E5; Cell Signaling Technology). Mouse monoclonal an-
tibody against α- tubulin (clone DM1A; Abcam, Cambridge, 
United Kingdom) was used for a protein loading control.
2.5 | Culture of primary neurons and axonal 
trafficking assay
Primary neurons were cultured from the hippocampus 
and cortex of p38fl/flNexcre/wt and p38fl/flNexcre/wt embryos 
(E14  ±  0.5) with our established method.17 After 7  days, 
cultured neurons were transfected with vectors encoding 
a fusion protein of BACE1 and monomeric green fluores-
cent protein (GFP) on C- terminus (kindly provided by 
S. Weihong, Centre for Brain Health, Vancouver, Canada)21 
in Lipofectamine 2000 (Thermo Fisher Scientific). Ten hours 
after transfection, the trafficking of BACE1- GFP in neuronal 
processes was measured with time- lapse imaging in a cham-
ber at 37°C and filled with 5% CO2 under Zeiss LSM 780 
confocal microscopy (Göttingen, Germany). A total of 60 
frames of time- lapse sequences were collected at 5- seconds 
intervals. The argon laser was used with 1% of intensity to 
minimize laser- induced bleaching of fluorescence and injury 
of cells. ImageJ with plugin MTrackJ was used to analyze the 
trafficking of BACE1.22
2.6 | In vitro kinase assay
We incubated 5.5  ng active p38α- MAPK kinase (cat. 
V2701; Promega GmbH, Walldorf, Germany), 150  µM 
ATP and recombinant human Snapin protein (cat. pro- 
663; ProSpec- Tany TechnoGene Ltd., Ness- Ziona, Israel) 
at increasing concentrations (0, 0.15, 0.24 and 0.3 µg/µL) 
for 60  minutes at RT in a white solid 96- well plate (cat. 
3912; Corning GmbH, Wiesbaden, Germany). Thereafter, 
the ADP release from p38α- MAPK- mediated phosphoryla-
tion of Snapin was measured with ADP- Glo Kinase Assay 
(cat. V9101; Promega) on a luminescence reader, GloMax 
Navigator (Promega).
2.7 | Establishment of SH- SY5Y cell lines
p38α- MAPK knock- down cell lines (kd509 and kd709) as 
well as their control cells (kd- ct) were established in our 
previous study.10 Snapin- overexpressing cell lines were 
constructed by stably transfecting SH- SY5Y cells with a 
pcDNA3.1+/C- (K)- DYK vector encoding human Snapin 
(OHu56032D) (wt) and vectors encoding Snapins contain-
ing point mutations from serine to alanine at 112 (S112A; 
AGT → GCC) and 133 (S133A; TCC → GCC) (all vec-
tors were provided by GenScript, Leiden, the Netherlands). 
The over- expressed Snapin was tagged with FLAG at 
C- terminal. Thereafter, Snapin- overexpressed cell lines 
were further transfected with MAPK14 knock- down (709 
kd) and control (kd- ct) vectors as described in our previous 
study.10
2.8 | Phosphorylation analysis with liquid 
chromatography electrospray ionization 
tandem mass spectrometry
FLAG- tagged Snapin was isolated from SH- SY5Y cells with 
and without MAPK14 knock- down and purified with SDS/
PAGE. The coomassie stained bands were cut from the gel 
and subjected to in- gel digestion with trypsin.23 Peptides 
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were extracted from the gel pieces by sonication for 15 min-
utes, followed by centrifugation and supernatant collection. A 
solution of 50:50 water: acetonitrile, 1% formic acid (2 × the 
volume of the gel pieces) was added for a second extraction. 
The supernatant was pooled and processed using speed vac-
uum centrifugation. The samples were then dissolved in 10 µL 
of reconstitution buffer (96:4 water: acetonitrile, 1% formic 
acid) and analyzed by liquid chromatography electrospray 
ionization tandem mass spectrometry. An UltiMate 3000 
RSLC nano LC system (Dionex; Thermo Fisher Scientific) 
fitted with a trapping cartridge (µ- Precolumn C18 PepMap 
100, 5 µm, 300 µm i.d. × 5 mm, 100 Å) and an analytical 
column (nanoEase M/Z HSS T3 column 75 µm × 250 mm 
C18, 1.8 µm, 100 Å, Waters) was used. Trapping was carried 
out with a constant flow of trapping solvent (0.05% trifluoro-
acetic acid in water) at 30 µL/min onto the trapping column 
for 6 minutes. Subsequently, peptides were eluted and sepa-
rated on the analytical column using a gradient composed of 
Solvent A (3% DMSO, 0.1% formic acid in water) and sol-
vent B (3% DMSO, 0.1% formic acid in acetonitrile) with a 
constant flow of 0.3 µL/min. During the analytical separa-
tion, the percentage of solvent B was stepwise increased from 
2% to 4% in 6 minutes, from 4% to 8% in 1 minute, then from 
8% to 25% for a further 41 minutes and finally from 25% to 
40% in another 5 minutes. The outlet of the analytical column 
was coupled directly to an Orbitrap Fusion Lumos (Thermo 
Fisher Scientific) mass spectrometer using the nanoFlex 
source. The peptides were introduced into the Orbitrap 
Fusion Lumos via a Pico- Tip Emitter 360 µm OD × 20 µm 
ID; 10 µm tip (New Objective) and an applied spray voltage 
of 2.4 kV, instrument was operated in a positive mode. The 
capillary temperature was set at 275°C. Full mass scans were 
acquired for a mass range 375- 1200 m/z in profile mode in 
the orbitrap with resolution of 120 000. The filling time was 
set to a maximum of 50 microseconds with a limitation of 
4e5 ions. The instrument was operated in a data- dependent 
acquisition (DDA) mode and MSMS scans were acquired in 
the Orbitrap with a resolution of 30 000, with a fill time of 
up to 86 microseconds and a limitation of 2e5 ions (AGC tar-
get). A normalized collision energy of 34 was applied. MS2 
data was acquired in a profile mode. Acquired data was pro-
cessed by IsobarQuant. As a search engine Mascot (v2.2.07) 
was used.24 Data was searched against Uniprot Homo sapi-
ens proteome database (UP000005640) containing common 
contaminants, reversed sequences and the sequences of the 
proteins of interest. The data was searched with the following 
modifications: Carbamidomethyl (C; fixed modification), 
Acetyl (N- term), Oxidation (M) and Phospho (STY) (vari-
able modifications). The mass error tolerance for the full scan 
MS spectra was set to 10 ppm and for the MS/MS spectra to 
0.02 Da. A maximum of two missed cleavages was allowed. 
For protein identification, a minimum of two unique peptides 
with a peptide length of at least seven amino acids and a false 
discovery rate below 0.01 were required on the peptide and 
protein level.
2.9 | Snapin phosphorylation assay in 
cultured SH- SY5Y cells
Cell lysate was prepared from SH- SY5Y cells over- 
expressing FLAG- tagged wild- type, and mutated (S112A or 
S133A) Snapins. Snapin proteins were purified with FLAG 
Immunoprecipitation Kit and the ANTI- FLAG M2 Affinity 
Gel (Sigma- Aldrich) according the manufacturer's instruc-
tion (Merck KGaA). The phosphorylation of FLAG- tagged 
Snapin was detected with Western blot using mouse mon-
oclonal antibody against phospho- serine (clone PSR- 45; 
Merck KGaA).
2.10 | β- secretase activity and protein assays 
in cultured SH- SY5Y cells
To measure β- secretase activity, membrane components were 
prepared from SH- SY5Y cells over- expressing wild- type and 
mutated Snapins with and without knockdown of p38α- MAPK 
expression.25 Membrane components were incubated with 
fluorogenic substrate of β- secretase at 37°C (Merck KGaA). The 
fluorescence intensity in each well was measured for 73 cycles 
with intervals of 5 minutes with Synergy Mx Monochromator- 
based Multi- mode Microplate Reader (BioTek, Winooski, 
VT, USA). Fluorescence intensity of the first cycle was used 
as background. Membrane components were further lysed in 
buffer A, and detected with Western blot using BACE1 anti-
body (clone D10E5; Cell Signaling Technology).
2.11 | Subcellular fractionation by sucrose 
density gradient centrifugation
Subcellular fractions were prepared as described previ-
ously.26,27 SH- SY5Y cells were harvested, washed with PBS 
and centrifuged at 300 g for 8 minutes. Cells were homog-
enized in TBS supplemented with protease inhibitor cocktail 
(Merck KGaA) by passaging 10 times through a 26- gauge 
needle. Nuclei and cell debris were removed by centrifuga-
tion at 1000 g for 10 minutes. The supernatant was transferred 
and centrifuged at 34 000 g for 15 minutes. The supernatant 
(S2), containing cytosolic proteins, was collected and used 
later as a purity control. The pellet was resuspended in 2 mL 
45% sucrose in TBS and loaded on the bottom of a tube (cat. 
344059; Beckman), which was overlaid by 6  mL 34.5% 
and 4 mL 14.3% sucrose buffer. After ultracentrifugation at 
107 000 g for 12 hours, the cell lysate was separated into 12 
fractions (1  mL per each) from the top to the bottom. For 
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Western blot analysis, all subcellular fractions with an equal 
volume were loaded onto PAGE gel and antibodies against 
LAMP1 (clone C54H11; Cell Signaling Technology), cal-
nexin (cat. ab22595; Abcam) and α- tubulin (clone DM1A; 
Abcam) were used.
2.12 | Statistics
Data were presented as mean  ±  SEM. For multiple com-
parisons, we used one- way or two- way ANOVA followed 
by Bonferroni, Tukey, or Dunnett T3 post hoc test (depend-
ent on the result of Levene's test to determine the equality 
of variances). Two independent- samples Student's t test was 
used to compare means for two groups of cases. All statis-
tical analyses were performed with SPSS version 19.0 for 
Windows (IBM, New York, NY, USA). Statistical signifi-
cance was set at P < .05.
3 |  RESULTS
3.1 | Deletion of p38α- MAPK in neurons 
reduces Snapin phosphorylation in APP- 
transgenic mouse brain
We recently observed that deletion of p38α- MAPK in neurons 
decreases BACE1 in the brain of APP- transgenic mice.10,17 At the 
beginning of this study, we re- confirmed our result by detecting 
BACE1 proteins in brains of APPtgp38fl/flNexcre/wt (p38α- MAPK 
deficient) and APPtgp38fl/flNexwt/wt (p38α- MAPK wild- type) lit-
termate mice (Figure 1A; t test, P < .05). As Snapin potentially 
promotes the retrograde transportation and lysosomal degrada-
tion of BACE1,2,14,28 we hypothesized that p38α- MAPK might 
phosphorylate Snapin and modify its function. Thus, we used 
NetPhosK 1.0 Server to predict the potential phosphorylation 
sites on Snapin using the UniProt accession number of O95295. 
p38α- MAPK potentially phosphorylates Snapin at serine sites 
6, 10, 50, 112, 126 and 133, and at threonine sites 14 and 117.
We then immunoprecipitated Snapin from brain homoge-
nates of p38α- MAPK- deficient and wild- type mice. We did 
observe that deletion of p38α- MAPK in neurons significantly 
decreased the phosphorylation level of Snapin at serines 
(Figure 1B; t test; P < .05), but not at threonines (Figure 1C; 
t test; P > .05).
3.2 | Deletion of p38α- MAPK in neurons 
reduces Snapin and BACE1 at axonal terminals 
in APP- transgenic mice
To investigate whether the reduced phosphorylation of Snapin 
changed the axonal transportation in p38α- MAPK- deficient 
mouse brain, we stained Snapin in hippocampi of APPtgp38fl/
flNexcre/wt and APPtgp38fl/flNexwt/wt mice (Figure  2A). 
Interestingly, the length of Snapin antibody- stained linear 
structures was two- fold more in p38α- MAPK- deficient APP- 
transgenic mice (0.091 ± 0.004 µm) than in p38α- MAPK wild- 
type AD littermate mice (0.046 ± 0.004 µm) (Figure 2B; t test, 
P < .001). We divided Snapin- positive structures into different 
F I G U R E  1  Deletion of p38α- MAPK in neurons reduces BACE1 and Snapin phosphorylation in APP- transgenic mice. Brain homogenates 
were prepared from 9- month- old APP- transgenic mice with (ko) and without (wt) deletion of p38α- MAPK in neurons. BACE1 was detected with 
Western blot (A; t test; n = 5 per group). Snapin was first pulled down and then detected with Western blot using antibodies against phospho- serine 
or phospho- threonine, and Snapin. The phosphorylation level of Snapin at serine was significantly decreased (B; t test; n = 5 per group), whereas 
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groups according to their length (< 1, 1- 5, 5- 10 and >10 µm). 
Deletion of p38α- MAPK predominantly increased the percent-
ages of long (5- 10 and >10 µm) fragments (Figure 2C; two- way 
ANOVA, P < .05).
In following experiments, we isolated synaptosomes 
from the brain of APPtgp38fl/flNexcre/wt and APPtgp38fl/fl-
Nexwt/wt mice. The synaptosomal fraction was enriched with 
synaptic proteins, such as Grin2a, PSD95, and lack of cyto-
solic protein, HDAC3, indicating the success of our isolation 
experiments (Figure  2D). In synaptosomal fractions from 
APPtgp38fl/flNexcre/wt mice, the protein level of p38α- MAPK 
was about 72% lower than that in APPtgp38fl/flNexwt/wt mice 
(Figure 2E; t test, P < .001). Quantitative Western blot re-
vealed that the protein level of Snapin decreased by 38% 
(Figure 2F; t test, P < .001) and that of BACE1 decreased 
by 51% (Figure 2G; t test, P <  .05) in synaptosomes from 
p38α- MAPK- deficient APP- transgenic mice compared to 
p38α- MAPK- wild- type APP mice. Thus, deletion of p38α- 
MAPK appeared to drive Snapin and BACE1 to leave syn-
aptic terminals.
3.3 | Deletion of p38α- MAPK 
increases BACE1 trafficking in primary 
cultured neurons
As we observed that p38α- MAPK deficiency re- located Snapin 
and BACE1 in the brain, we assumed that p38α- MAPK should 
regulate the trafficking of BACE1 in axons. We over- expressed 
a fusion protein of BACE1 and its C- terminal- tagged GFP 
F I G U R E  2  Deletion of p38α- MAPK in neurons re- locates Snapin and decreases Snapin and BACE1 in synaptosomes in APP- transgenic mice. 
Immunofluorescent labelling of Snapin was performed to evaluate the subcellular distribution of Snapin in 9- month- old APP- transgenic mice with 
(ko) and without (wt) deletion of p38α- MAPK in neurons (A). Snapin staining- positive neuronal processes in cropped region were skeletonized and 
measured for the length (A). The total length of Snapin antibodies— reactive processes adjusted by the area of region analyzed was significantly 
longer in p38α- MAPK ko mice than in p38α- MAPK wt mice (B; t test; n ≥ 5 per group). Binning analysis (C) revealed a higher proportion of 
short and lower proportions of long Snapin staining in p38α wt than p38α ko animals (two- way ANOVA; n ≥ 6 per group). Synaptosomes were 
further isolated from 9- month- old p38α- MAPK- ko and - wt APP- transgenic mice. Purity of isolated synaptosomes (S) was examined by detecting 
synaptosomal (Grin2a, PSD95) and cytoplasmic (HDAC3) proteins. Cytoplasmic fraction was used as a control (D). Thereafter, p38- MAPK, 
Snapin and BACE1 were quantitated in isolated synaptosomes with Western blot (E- G). Deletion of p38α- MAPK significantly decreased the 
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in p38α- MAPK- deficient and wild- type cultured neurons. 
Time- lapse images of neurons were taken under a confocal 
microscope. Serial frames of the image stack were depicted 
(Figure  3A,B). BACE1- GFP particles in p38α- MAPK wild- 
type neurons moved with significantly shorter distance 
(Figure 3C; wt: 4.68 ± 0.58 µm and ko: 17.68 ± 3.02 µm; t test, 
P < .001) and slower velocity (Figure 3D; wt: 6.96 ± 0.88 µm/
min and ko: 33.88 ± 5.90 µm/min; t test, P < .001) than in p38α- 
MAPK- deficient neurons. Moreover, p38α- MAPK wild- type 
neurons displayed more stationary BACE1- GFP particles than 
p38α- MAPK- deficient neurons (Figure 3E; wt: 41.91 ± 3.35% 
of total particles and ko: 11.14 ± 3.98% of total particles; t test, 
P < .001). Thus, p38α- MAPK deficiency promoted the axonal 
transport of BACE1, which was in accordance with our obser-
vation in p38α- MAPK- deficient mouse brain.
3.4 | p38α- MAPK phosphorylated Snapin 
at serine residue 112
Our experiments described above suggested that p38α- 
MAPK regulated BACE1 transportation in axons potentially 
through phosphorylating Snapin. We directly incubated the 
recombinant p38α- MAPK and Snapin in the presence of 
ATP. As shown in Figure 4A, as the amount of Snapin used 
in the reaction increased, the conversion of ATP to ADP, 
as shown in luminance intensity, increased, indicating that 
p38α- MAPK can phosphorylate Snapin.
We used our previously constructed p38α- MAPK- 
knocked down (kd709 and kd509) and wild- type (kd- ct) 
SH- SY5Y cell lines.10 The protein level of p38- MAPK was 
significantly decreased by knock- down of MAPK14 gene 
(Figure 4B; one- way ANOVA; P < .05). We observed that 
deletion of p38α- MAPK significantly reduced phosphory-
lation of Snapin at serine by ~40% in kd709 and by ~50% 
in kd509 compared with kd- ct cells (Figure 4C; one- way 
ANOVA; P <  .05). Deletion of p38α- MAPK altered nei-
ther phosphorylation at threonine nor the total amount of 
Snapin (data not shown).
We then constructed new SH- SY5Y cell lines over- 
expressing FLAG- tagged Snapin with (kd709) and without 
(kd- ct) knock- down of p38α- MAPK. We purified FLAG- 
tagged Snapin for mass spectrometry analysis. The sequence 
detected in several independently repeated experiments cov-
ered 58%- 75% of Snapin sequence. The serines at position 
112 (S112) and 133 (S133) were identified in p38α- MAPK 
wild- type cells (kd- ct) for the phosphorylation modification 
with a delta mod value >40 and a Mascot peptide score >32 
(Figure  4D,E). Other identified serine and threonine sites 
with potential phosphorylation had either low Mascot peptide 
scores or small delta mod values, which indicated that these 
amino acids were not phosphorylated or their low phosphory-
lation levels were below the detection sensitivity of mass spec-
trometry.29 Interestingly, in p38α- MAPK- deficient SH- SY5Y 
cells, the phosphorylation on S112 was undetectable, which 
strongly suggested that S112 was the phosphorylation site of 
p38α- MAPK.
To verify the finding from mass spectrometry analysis, 
we continued to constructed FLAG- tagged Snapin- transgenic 
SH- SY5Y cells, in which serine 112 (S112) or serine 133 
F I G U R E  3  Deletion of p38α- MAPK promotes BACE1 trafficking in cultured neurons. BACE1- GFP fusion protein was expressed in 
hippocampal neurons cultured from p38α- MAPK- deficient (ko) and wild- type (wt) mice. Its trafficking was analyzed by serially imaging neurons 
under confocal microscopy with an interval of 5 seconds for total 60 frames. BACE1- GFP particles were followed along the axon in retrograde 
direction (p38α- MAPK wt: A1- A4, and ko: B1- B4; scale: 10 µm). The white arrowheads mark the traced BACE1- GFP particles over time and the 
asterisks in A1 and B1 mark stationary particles. The track length (C) and the velocity (D) of BACE1- GFP particles was significantly increased in 
p38α- MAPK ko neurons than in wt cells (t test; n ≥ 14 neurons and ≥68 particles per group). p38α- MAPK wt neurons showed significantly higher 
percentage of stationary BACE1- GFP particles (t test; n ≥ 6 neurons and ≥180 particles per group)
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(S133) in Snapin was replaced with alanine (Figure 4F). These 
cell lines were further knocked down for the expression of 
p38α- MAPK. The expression of FLAG- tagged Snapins was 
detected with Western blot (Figure 4G). In various Snapin- 
expressing cell lines, p38α- MAPK proteins were similarly 
reduced (40%- 50%) after transfection of knock- down vector 
(kd709) compared with transfection of control vector (kd- ct) 
(Figure 4H; t test; P < .05). With these cell lines, we again 
observed that deletion of p38α- MAPK inhibited the phos-
phorylation of wild- type Snapin at serine (Figure 4I; t test; 
P =  .003); however, the serine phosphorylation was nearly 
undetectable in S112A- mutated FLAG- tagged Snapin with 
both knocked down and normal expression of p38α- MAPK in 
cells. In S133A- mutated FLAG- tagged Snapin, p38α- MAPK 
deficiency even tended to increase the phosphorylation at 
serine. These experiments supported that p38α- MAPK phos-
phorylates Snapin at residue S112.
3.5 | S112A mutation on Snapin abolished 
p38α- MAPK- induced protein reduction and 
lysosomal distribution of BACE1 in SH- 
SY5Y cells
As Snapin regulates trafficking of BACE114,15 from en-
dosomes to lysosomes in neurons, we assumed that the 
over- expressed mutated Snapin should interfere with the 
endogenous Snapin in the regulation of BACE1 levels and 
subcellular localization. We measured β- secretase activity 
and proteins in the membrane components prepared from 
SH- SY5Y cells. In SH- SY5Y cells over- expressing FLAG- 
tagged wild- type Snapin, p38α- MAPK deficiency reduced 
both the activity and protein of BACE1 (Figure 5A,B; t test; 
P  <  .05), which corroborated our previous observation.10 
However, in SH- SY5Y cells over- expressing S112A- mutated 
Snapin, knock- down of p38α- MAPK changed neither activ-
ity nor proteins of BACE1. Moreover, in SH- SY5Y cells 
over- expressing S133A- mutated Snapin, p38α- MAPK defi-
ciency decreased the activity and protein level of BACE1, 
with a stronger effect than in wild- type Snapin- expressed 
cells (Figure 5A,B; t test; P < .05).
In further experiments, we detected BACE1 in subcellu-
lar fractions. The lysosome marker, LAMP1, was enriched 
in fraction 5 and 10. As fraction 5 was also positive for cal-
nexin, a protein of endoplasmic reticulum, we considered 
fraction 10 as the fraction of lysosomes (Figure 5C,D). The 
cytoskeleton protein, α- tubulin, was absent in all subcellu-
lar fractions and only detectable in the cytosolic supernatant 
S2. We detected BACE1 proteins and quantified its relative 
amount in all fractions. When calculating the ratio of BACE1 
amount in the lysosomal fraction (No. 10) among the total 
BACE1 protein in all subcellular fractions, we observed that 
p38α- MAPK deficiency increased the distribution of BACE1 
in the lysosomal fraction in wild- type Snapin- expressing 
cells (Figure  5E- G; 3.1  ±  0.6% vs 12.7  ±  2.6% in p38α- 
MAPK- wildtype and knocked down cells, respectively; t test, 
P < .05), which corroborates our previous finding.10 However, 
in S112A- mutated Snapin- expressing cells, p38α- MAPK de-
ficiency did not alter the distribution of BACE1 in lysosomes 
(Figure 5H- J; t test, P > .05). As a control, in S133A- mutated 
Snapin- expressing SH- SY5Y cells, deficiency of p38α- 
MAPK served the same effect on BACE1 distribution as in 
wild- type Snapin- expressing cells (Figure 5K- M; 3.6 ± 1.0% 
vs 7.3 ± 0.4% in p38α- MAPK- wildtype and knocked down 
cells, respectively; t test, P < .05). Thus, our results support 
that p38α- MAPK phosphorylates Snapin on S112 and sub-
sequently inhibits the lysosomal distribution of BACE1 in 
neuronal cells.
F I G U R E  4  p38α- MAPK phosphorylates Snapin at serine residue 112. In the in vitro kinase assay, 5.5 ng of recombinant p38α- MAPK was 
incubated with recombinant Snapin in the presence of 150 μM ATP. The conversion of ATP to ADP was shown in luminance intensity. The 
production of ADP increases with the amount of Snapin proteins used (A; shows results from one of the two independently repeated experiments). 
SH- SY5Y cells were stably transfected with p38α- MAPK knock- down (kd709, kd509) and control (kd- ct) vectors. The protein levels of p38- 
MAPK in kd709 and kd509 cells were ~50% of that in kd- ct cells (B; one- way ANOVA followed by Bonferroni post hoc test; n ≥ 3 per group). 
Snapin was pulled down from cell lysate with anti- Snapin antibody and detected with antibodies against phospho- serine. Knock- down of p38α- 
MAPK significantly attenuated Snapin phosphorylation in kd709 and kd509 cells compared with kd- ct controls (C; one- way ANOVA followed 
by Bonferroni post hoc test; n ≥ 3 per group). In following experiments, SH- SY5Y cell lines were constructed to over- express FLAG- tagged 
Snapin with and without knock- down of p38α- MAPK (kd709 and kd- ct, respectively). FLAG- tagged Snapin was isolated and purified for mass 
spectrometry analysis. The detected sequence covered >75% of whole sequence of Snapin. Sequenced amino acids were coded in grey (without 
modifications), blue (with minor phosphorylation; Mascot peptide score <32) and yellow (with high- level phosphorylation; Mascot peptide score 
≥32). Serine sites S112 and S133 highlighted in red were detected in p38α- MAPK kd- ct cells with highest mascot peptide scores and delta mod 
values ≥20 (D). In p38α- MAPK kd709 cells, phosphorylation of S112 was undetectable (E). To verify the results from mass spectrometry analysis, 
new SH- SY5Y cell lines over- expressing wild- type (wt), and S112A or S133A- mutated FLAG- tagged Snapins with (kd709) and without (kd- ct) 
knock- down of p38α- MAPK were further constructed (F and G). The knock- down of p38α- MAPK led to similar reduction of p38- MAPK in Snapin 
wt, S112A and S133A cell lines (H; t test; n ≥ 3 per group). Finally, the immunoprecipitated FLAG- tagged Snapin was detected with phospho- 
serine- specific antibodies. Knock- down of p38α- MAPK significantly reduce phosphorylation of wt Snapin on serine residues (H, t test; n ≥ 3 per 
group). However, the phosphorylation was nearly undetectable on S112A- mutated Snapin and the phosphorylation of S133A- mutated Snapin was 
not altered by p38α- MAPK deficiency (I, t test; n ≥ 3 per group)
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4 |  DISCUSSION
Axonal transport, especially retrograde transport, is damaged in 
AD at the early disease stage,30,31 which forms an AD- hallmark 
of neuritic dystrophy.32 We previously observed that deletion 
of p38α- MAPK in neurons promotes lysosomal BACE1 deg-
radation and attenuates Aβ deposits in APP- transgenic mouse 
brain.10 In this study, we further demonstrated that p38α- 
MAPK deficiency reduces phosphorylation of Snapin, which 
might facilitate the transport of BACE1 into lysosomes.
Snapin can be phosphorylated by various kinases such as 
casein kinase 1δ,33 protein kinase A34 and leucine- rich re-
peat kinase 2.35 In our study, we identified p38α- MAPK as 
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results: (a) deletion of p38α- MAPK in neurons decreases 
phosphorylation level of Snapin in APP- transgenic mice; (b) 
mass spectrometry analysis reveals phosphorylation at serine 
112 (S112) on Snapin in p38α- MAPK wild- type SH- SY5Y 
cells, but not in p38α- MAPK- deficient cells; (c) replacement 
of S112 with alanine abolishes p38α- MAPK- mediated phos-
phorylation of Snapin and p38α- MAPK deficiency- induced 
reduction of BACE1 in SH- SY5Y cells; and (d) p38α- MAPK 
directly phosphorylates recombinant Snapin protein in an in 
vitro kinase assay. Our results are in accordance with a yeast 
two- hybrid screening experiment, which showed that p38α- 
MAPK likely binds to Snapin.36
It should be noted that phosphorylation of Snapin might 
inhibit its physiological function. For example, phosphoryla-
tion at threonine 117 by the leucine- rich repeat kinase 2 re-
sults in its lower binding to SNARE complex and impairs the 
exocytosis of vesicles.32 Our examination on APP- transgenic 
mouse brain showed that deletion of p38α- MAPK increases 
the immuno- fluorescent staining of Snapin along axons and 
decreases protein levels of Snapin in synaptosomes, which 
suggests that the less phosphorylated Snapin is more active 
in the transportation of BACE1 from the axonal terminal to 
the soma. In cultured neurons, we did observe that p38α- 
MAPK deficiency promotes BACE1 trafficking along neuro-
nal processes, although it remains unclear whether reduction 
of phosphorylation on Snapin is a driving force. To answer 
this question, we need to mask p38α- MAPK- phosphorylating 
sites (ie, S112) on Snapin in primary cultured neurons, which 
is technically difficult.
It has been reported that an efficient shipment of BACE1 
from endosomes into lysosomes is necessary for a suffi-
cient degradation of BACE1.27 As a dynein motor adaptor, 
Snapin does regulate trafficking of BACE114,15 from the 
late endosomes to lysosomes in neurons. In SH- SY5Y cells, 
we over- expressed S112A- mutated Snapin, which deleted 
p38α- MAPK- mediated phosphorylation of Snapin. We did 
observe that p38α- MAPK deficiency- induced reduction of 
BACE1 proteins and its enhanced lysosomal distribution was 
abolished. Thus, p38α- MAPK might not only regulate axonal 
transportation but also affect Snapin- involved trafficking of 
proteins between subcellular organelles.
Besides phosphorylating Snapin, p38α- MAPK might 
also regulate axonal transportation of BACE1 through other 
mechanisms. Tau interacts with tubulin and stabilizes cyto-
skeleton under physiological conditions.37- 39 Tau becomes 
hyper- phosphorylated and detaches skeleton in AD, which 
impairs protein trafficking in axons.40- 44 Our recent study 
showed that deletion of p38α- MAPK prevents Tau from hyper- 
phosphorylation in neurons.17 We also observed that the tran-
scription of dynein cofactor dynactin 1 (Dctn1) is up- regulated 
in p38a- MAPK- deficient APP- transgenic mice.17 Silencing 
genes encoding dynein/dynactin complex was observed to 
block retrograde transport and exaggerate the axonal pathol-
ogy in Tau- overexpressed Drosophila.45 However, to clarify 
these potential mechanisms, we need further experiments.
Abnormal axonal transport, especially retrograde trans-
port, and loss of axonal architecture are common features 
of axonopathies, not only in AD, but also in other neurode-
generative diseases, such as amyotrophic lateral sclerosis, 
Huntington's, and Parkinson's diseases. As Snapin serves as 
an adaptor protein of dynein in retrograde transport,15 p38α- 
MAPK inhibition might also protect axons in various neuro-
degenerative diseases.
In our recent study, we observed that deficiency of p38α- 
MAPK inhibits NMDA receptor- mediated calcium influx 
and enhances the clearance of calcium from the cytosol of 
neurons, which might prevent calcium overload- induced neu-
ronal death at AD lesion sites (eg, around Aβ deposits).17 
However, calcium is essential for the neuronal excitability, 
neurotransmitter release, and synaptic plasticity, under mod-
erate concentrations.46 Our previous studies revealed that 
Snapin enhances the association between synaptotagmin, a 
calcium- binding protein, and SNARE proteins, and facilitates 
the secretion of large dense- core vesicles from chromaffin 
cells.47,48 Thus, p38α- MAPK deficiency might improve the 
neuronal function by activating Snapin in relatively healthy 
F I G U R E  5  Replacement of serine 112 with alanine in Snapin abolishes p38α- MAPK deficiency- induced reduction of BACE1 activity and 
protein, and lysosomal transportation. Membrane components were prepared from p38α- MAPK- knocked down (kd) and wild- type (ct) SH- 
SY5Y cells over- expressing FLAG- tagged wild- type (wt), S112A or S133A- mutated Snapin. β- secretase activity was measured by incubating 
membrane components with fluorogenic β- secretase substrates at 37°C for 6 h. The protein level of BACE1 in isolated membrane components was 
determined by quantitative Western blot. Knock- down of p38α- MAPK significantly decreases both β- secretase activity and BACE1 protein in wt 
Snapin- overexpressing cells, however, alters neither in S112A- mutated Snapin- overexpressing cells (A and B; t test; n ≥ 3 per group). In S133A- 
mutated Snapin- overexpressing cells, knock- down of p38α- MAPK significantly decreases both β- secretase activity and BACE1 protein even with 
stronger effects than in wt Snapin- overexpressing cells (A and B; t test; n ≥ 3 per group). Subcellular fractions were prepared from wt, and S112A 
or S133A- mutated Snapin- overexpressing cells using sucrose density gradient centrifugation. Fraction no. 10 was enriched with LAMP1, but 
absent for calnexin and α- tubulin, as detected with Western blot, and then considered as the lysosomal fraction (C and D). Thereafter, subcellular 
fractions and cytosolic supernatant (S2) were immunoblotted for BACE1 (E, H and K). The amount of BACE1 in different subcellular fractions 
was quantified and the ratio of BACE1 in fraction 10 among the total BACE1 protein in all fractions was calculated (F, I and L). The distribution of 
BACE1 in lysosomal fraction was significantly increased by knocking down of p38α- MAPK in wt and S133A- mutated Snapin- overexpressing cells 
(E- G and K- M; t test; n = 3 per group), but not in S112A- mutated Snapin- overexpressing cells (H- J; t test, P > .05; n = 3 per group)
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brain regions in AD. The binding between Snapin and SNAP- 
25 requires the phosphorylation of Snapin at serine 50 by 
protein kinase A.34 How p38α- MAPK- mediated phosphory-
lation regulates the function of Snapin and subsequent neuro-
nal exocytosis needs a further investigation.
In summary, our studies showed that deletion of p38α- 
MAPK decreases phosphorylation of Snapin at serine resi-
due 112 and enhances transportation of BACE1 from axonal 
terminals to lysosomes in the cell body, which might lead to 
BACE1 reduction and improve amyloid pathology in p38α- 
MAPK- deficient AD mice.10,17 Our results contribute to a 
better understanding of molecular mechanisms underlying 
AD pathogenesis.
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